466 related articles for article (PubMed ID: 18195664)
1. Patient and family fact sheet. Myasthenia gravis: maximizing function.
Kernich CA
Neurologist; 2008 Jan; 14(1):75-6. PubMed ID: 18195664
[No Abstract] [Full Text] [Related]
2. Management of myasthenia gravis.
Saperstein DS; Barohn RJ
Semin Neurol; 2004 Mar; 24(1):41-8. PubMed ID: 15229791
[TBL] [Abstract][Full Text] [Related]
3. [Myasthenia gravis; clinical aspects, pathophysiology and treatment].
Oosterhuis HJ
Ned Tijdschr Geneeskd; 1983 Sep; 127(39):1765-71. PubMed ID: 6314161
[No Abstract] [Full Text] [Related]
4. Myasthenia gravis.
Kothari MJ
J Am Osteopath Assoc; 2004 Sep; 104(9):377-84. PubMed ID: 15452103
[TBL] [Abstract][Full Text] [Related]
5. Myasthenia gravis: diagnosis.
Meriggioli MN; Sanders DB
Semin Neurol; 2004 Mar; 24(1):31-9. PubMed ID: 15229790
[TBL] [Abstract][Full Text] [Related]
6. [Myasthenia gravis. Recent findings and their therapeutic consequences].
Thümler R; Haferkamp G
Dtsch Med Wochenschr; 1979 Oct; 104(40):1415-20. PubMed ID: 227650
[No Abstract] [Full Text] [Related]
7. [Problems of resuscitation during thymectomy in myasthenia].
Noviant Y; Gaud C; Levasseur P
Anesth Analg (Paris); 1973; 30(1):147-75. PubMed ID: 4721991
[No Abstract] [Full Text] [Related]
8. Overview of myasthenia gravis.
Arora Y; Li Y
Hosp Pract (1995); 2013; 41(4):40-50. PubMed ID: 24145588
[TBL] [Abstract][Full Text] [Related]
9. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Cole RN; Reddel SW; Gervásio OL; Phillips WD
Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of myasthenia gravis.
Dipalma JR
Am Fam Physician; 1980 Oct; 22(4):158-9. PubMed ID: 7424763
[No Abstract] [Full Text] [Related]
11. Dropped head as an unusual presenting sign of myasthenia gravis.
D'Amelio M; Di Benedetto N; Ragonese P; Daniele O; Brighina F; Fierro B; Savettieri G
Neurol Sci; 2007 Apr; 28(2):104-6. PubMed ID: 17464475
[TBL] [Abstract][Full Text] [Related]
12. The pharmacological basis for the treatment of myasthenia gravis.
Flacke W
Pharmacol Physicians; 1970 Jun; 4(6):1-7. PubMed ID: 4316342
[No Abstract] [Full Text] [Related]
13. Autoimmune disorders of neuromuscular transmission.
Mahadeva B; Phillips LH; Juel VC
Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
[TBL] [Abstract][Full Text] [Related]
14. [Neurophysiological monitoring of the myasthenia patient during and after thymectomy (author's transl)].
Bergmans J
Ann Chir; 1980 Mar; 34(3):182-7. PubMed ID: 6245617
[No Abstract] [Full Text] [Related]
15. [Myasthenia gravis--an autoimmune neuromuscular disease].
Pirskanen-Matell R; Matell G; Kalb B; Bjelak S
Lakartidningen; 2000 Oct; 97(41):4594-8. PubMed ID: 11107745
[No Abstract] [Full Text] [Related]
16. [Therapeutic considerations in myasthenia gravis].
Vejvalka J
Cesk Neurol Neurochir; 1984 Mar; 47(2):78-84. PubMed ID: 6705094
[No Abstract] [Full Text] [Related]
17. Myasthenia gravis: an overview.
Dreilinger CL
Ophthalmic Semin; 1976; 1(2):101-33. PubMed ID: 799277
[No Abstract] [Full Text] [Related]
18. Treatment of myasthenia--I.
Br Med J; 1971 Apr; 2(5754):160-2. PubMed ID: 4325739
[No Abstract] [Full Text] [Related]
19. The neuromuscular junction. Part II: myasthenia gravis.
Brumback RA
Am Fam Physician; 1981 Feb; 23(2):126-33. PubMed ID: 7457320
[TBL] [Abstract][Full Text] [Related]
20. Vocal cord paralysis in myasthenia gravis with anti-MuSK antibodies.
Hara K; Mashima T; Matsuda A; Tanaka K; Tomita M; Shiraishi H; Motomura M; Nishizawa M
Neurology; 2007 Feb; 68(8):621-2. PubMed ID: 17310039
[No Abstract] [Full Text] [Related]
[Next] [New Search]
